Lucis Raises $20 Million In Series A Funding Led By Singular For AI Healthcare Platform

Lucis, a developer of an AI-driven preventive healthcare platform, raised $20 million in Series A funding led by Singular, with participation from General Catalyst, Y Combinator, and others. The funding will be used to scale personalization capabilities, strengthen monitoring and clinical safety tools, and expand operations into Spain, Germany, and Italy by the end of 2026.

Summary of transaction details:

• Deal Type: Series A
• Transaction Amount: $20,000,000
• Company: Lucis
• Headquarters: Paris, France
• Founders: Maxime Berthelot & Baptiste Debever
• Investors: Singular, General Catalyst & Y Combinator
• User Base: Over 10,000 active users across several European markets

Lucis is co-founded by Maxime Berthelot and Baptiste Debever, focusing on a preventive health companion app that analyzes over 110 blood biomarkers. The app combines lab results with longitudinal tracking to generate personalized recommendations reviewed by physicians.